Literature DB >> 1337807

Immunizations for foreign travel.

D R Hill1.   

Abstract

One of the most important aspects of preparing travelers for destinations throughout the world is providing them with immunizations. Before administering any vaccines, however, a careful health and immunization history and travel itinerary should be obtained in order to determine vaccine indications and contraindications. There are three categories of immunizations for foreign travel. The first category includes immunizations which are routinely recommended whether or not the individual is traveling. Many travelers are due for primary vaccination or boosting against tetanus-diphtheria, measles-mumps-rubella, pneumococcal pneumonia, and influenza, for example, and the pre-travel visit is an ideal time to administer these. The second category are immunizations which might be required by a country as a condition for entry; these are yellow fever and cholera. The final category contains immunizations which are recommended because there is a risk of acquiring a particular disease during travel. Typhoid fever, meningococcal disease, rabies, and hepatitis are some examples. Travelers who are pregnant or who are infected with the human immunodeficiency virus require special consideration. Provision of appropriate immunizations for foreign travel is an important aspect of preventing illness in travelers.

Entities:  

Mesh:

Year:  1992        PMID: 1337807      PMCID: PMC2589588     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  60 in total

1.  Yellow fever virus activity--Trinidad and Tobago.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1989-02-03       Impact factor: 17.586

2.  Measles--United States, 1988.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1989-09-08       Impact factor: 17.586

Review 3.  Pneumococcal polysaccharide vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1989-02-10       Impact factor: 17.586

4.  Disseminated Mycobacterium bovis infection from BCG vaccination and HIV infection.

Authors:  P Boudes; A Sobel; L Deforges; E Leblic
Journal:  JAMA       Date:  1989-11-03       Impact factor: 56.272

5.  Serologic evidence of Cryptosporidium infection in US volunteers before and during Peace Corps service in Africa.

Authors:  B L Ungar; M Mulligan; T B Nutman
Journal:  Arch Intern Med       Date:  1989-04

6.  Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation.

Authors:  M M Levine; C Ferreccio; R E Black; R Germanier
Journal:  Lancet       Date:  1987-05-09       Impact factor: 79.321

7.  Protection against Japanese encephalitis by inactivated vaccines.

Authors:  C H Hoke; A Nisalak; N Sangawhipa; S Jatanasen; T Laorakapongse; B L Innis; S Kotchasenee; J B Gingrich; J Latendresse; K Fukai
Journal:  N Engl J Med       Date:  1988-09-08       Impact factor: 91.245

Review 8.  Human immunodeficiency virus infection and routine childhood immunisation.

Authors:  C F von Reyn; C J Clements; J M Mann
Journal:  Lancet       Date:  1987-09-19       Impact factor: 79.321

9.  Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants.

Authors:  J D Poland; C B Cropp; R B Craven; T P Monath
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

10.  Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV).

Authors:  J Berenguer; S Moreno; E Cercenado; J C Bernaldo de Quirós; A García de la Fuente; E Bouza
Journal:  Ann Intern Med       Date:  1989-07-15       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.